Efficacy and Safety of YW17 (Laronidase-CinnaGen) Compared to Aldurazyme® in MPS I Patients

Clinical trial NCT06406153 · COMPLETED

Trial details

NCT number: NCT06406153
Sponsor: Cinnagen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Mucopolysaccharidosis Type 1

Start date: 2022-09-10
Primary completion: 2023-08-12
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.